大流行
医学
H5N1导致的人类死亡率
流感疫苗
流感样疾病
中国
病毒学
甲型流感病毒
2019年冠状病毒病(COVID-19)
流感减毒活疫苗
病毒
免疫学
内科学
传染病(医学专业)
地理
疾病
考古
作者
Yinxia Su,Zihao Guo,Xia Gu,Shengzhi Sun,Kai Wang,Sheng‐Xue Xie,Shi Zhao
出处
期刊:Vaccine
[Elsevier]
日期:2023-09-01
卷期号:41 (39): 5683-5686
被引量:1
标识
DOI:10.1016/j.vaccine.2023.08.039
摘要
After the temporary end of COVID-19 in China in February 2023, the influenza epidemic peaked in March across many Chinese places. We recruited a total of 258 all-age subjects presenting influenza-like illness (ILI) in Shihezi city, China from January 1 to March 16, 2023, and tested for influenza virus infection. Using a test-negative design, we assessed influenza vaccine effectiveness (VE) of 56.3% (95% CrI: 13.6, 73.6) against medically attended, influenza illness during the delayed 2022/23 influenza epidemic. The findings contributed to the continuous monitoring of the influenza vaccine performance across the world, especially in the "post-COVID" pandemic era.
科研通智能强力驱动
Strongly Powered by AbleSci AI